0:000:00
<p>In this bold and wide-ranging conversation, Ian Wendt and Na-Ri Oh sit down with Andrew Craig—British investor, entrepreneur, and author—to explore how biotechnology is poised to shape the next century in the same way physics and computing shaped the last.</p>
<p> </p>
<p>Craig draws on his decades of experience as a London and New York investment banker and as a former partner at WG Partners, where he advised more than 60 biotech companies and worked on marquee deals like the $7.6B sale of Nordia Bank and IPOs for brands like EasyJet and Burberry.</p>
<p> </p>
<p>But his latest passion lies at the intersection of finance and innovation: making the case that our future is biotech, without a question mark.</p>
<p> </p>
<p>This episode originally aired on RealPharma, which is one of 10 shows in our new science podcast network, <a href='http://genepoolmedia.com/'>Gene Pool Media</a>. Thanks to everyone who has supported the network by following us @GenePoolMedia on social. Shoutout to ...